Massive Growth Co. Protects Health Pros & Patients: 2X Gains in 12 Months
I’m a firm believer in the power of modern medicine — and the massive growth the industry will experience in the decades ahead.
Read MoreI’m a firm believer in the power of modern medicine — and the massive growth the industry will experience in the decades ahead.
Read MorePosted by paul kranowitz | Aug 11, 2021
Stock highlights: Interactive Brokers, Volkswagen dethrones Tesla, Bonanza Creek, World Fuel and precious metals.
Read MorePosted by paul kranowitz | Aug 4, 2021
I recorded this week’s update from a farm in Paiján, Peru. Don’t worry if you don’t know where that is. I don’t really know where it is either. Today, I highlight two companies in our portfolio.
Read MorePosted by paul kranowitz | Jul 28, 2021
In this week’s video, I spotlight one of our “Imperium” stocks: immuno-pharma company AIM ImmunoTech Inc. (NYSE: AIM). A microcap stock, AIM is a speculative play, so please don’t bet the farm. However, in today’s update, I explain the multiple paths to success and profitability that I’ve identified for AIM.
Read MoreIn the July edition of our portfolio update, I revisit buy-up-to prices on three of our high-performing stocks.
Read MoreIn his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below